In the last 12 months, insiders at LENZ Therapeutics, Inc. ($LENZ) filed 118 transactions with the SEC: 10 open-market purchases totaling $16,206,027 and 36 sales totaling $66,864,161. Net insider sentiment: net selling.
LENZ Therapeutics, Inc. operates in the Biological products, (no disgnostic substances) industry (Life sciences sector).
Most Active Insiders
- Versant Venture Capital VI, L.P. (Not found) — 35 transactions totaling $66,603,139
- RA CAPITAL MANAGEMENT, L.P. (Not found) — 10 transactions totaling $15,000,075
- MCCOLLUM JAMES W (Director) — 8 transactions totaling $990,363
- Schimmelpennink Evert B. (President, CEO and Secretary) — 11 transactions totaling $302,579
- Olsson Shawn (Chief Commercial Officer) — 15 transactions totaling $291,667
View all SEC Filings for LENZ Therapeutics, Inc. (LENZ).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 27, 2026 | Chevallard Daniel R. | Chief Financial Officer | P | Common Stock | 7500 | $8.57 | 12,886.0000 | 31,289,969 | 139.25% | 0.02% |
| March 27, 2026 | George Jeffrey P. | Director | P | Common Stock | 5592 | $8.92 | 5,592.0000 | 31,289,969 | 9999.99% | 0.02% |
| March 27, 2026 | Schimmelpennink Evert B. | President, CEO and Secretary | P | Common Stock | 28089 | $8.95 | 77,289.0000 | 31,289,969 | 57.09% | 0.09% |
| Jan. 2, 2026 | Odrich Marc | Chief Medical Officer | A | Restricted Stock Unit | 14000 | $0.00 | 14,000.0000 | 31,289,969 | 9999.99% | 0.04% |
| Jan. 2, 2026 | Olsson Shawn | Chief Commercial Officer | A | Stock Option (right to buy) | 84200 | $0.00 | 84,200.0000 | 31,289,969 | 9999.99% | 0.27% |
| Jan. 2, 2026 | Olsson Shawn | Chief Commercial Officer | A | Restricted Stock Unit | 14000 | $0.00 | 14,000.0000 | 31,289,969 | 9999.99% | 0.04% |
| Jan. 2, 2026 | Odrich Marc | Chief Medical Officer | A | Stock Option (right to buy) | 84200 | $0.00 | 84,200.0000 | 31,289,969 | 9999.99% | 0.27% |
| Jan. 2, 2026 | Schimmelpennink Evert B. | President, CEO and Secretary | A | Stock Option (right to buy) | 358100 | $0.00 | 358,100.0000 | 31,289,969 | 9999.99% | 1.14% |
| Jan. 2, 2026 | Chevallard Daniel R. | Chief Financial Officer | A | Restricted Stock Unit | 14000 | $0.00 | 14,000.0000 | 31,289,969 | 9999.99% | 0.04% |
| Jan. 2, 2026 | Chevallard Daniel R. | Chief Financial Officer | A | Stock Option (right to buy) | 84200 | $0.00 | 84,200.0000 | 31,289,969 | 9999.99% | 0.27% |
| Nov. 17, 2025 | Olsson Shawn | Chief Commercial Officer | M | Common Stock | 10000 | $2.08 | 14,733.0000 | 31,289,969 | 211.28% | 0.03% |
| Nov. 17, 2025 | Olsson Shawn | Chief Commercial Officer | S | Common Stock | 4212 | $25.74 | 10,521.0000 | 31,289,969 | 28.59% | 0.01% |
| Nov. 17, 2025 | Olsson Shawn | Chief Commercial Officer | S | Common Stock | 5788 | $26.37 | 4,733.0000 | 31,289,969 | 55.01% | 0.02% |
| Nov. 17, 2025 | Olsson Shawn | Chief Commercial Officer | M | Stock Option (right to buy) | 10000 | $0.00 | 53,241.0000 | 31,289,969 | 15.81% | 0.03% |
| Nov. 7, 2025 | MCCOLLUM JAMES W | Director | P | Common Stock | 10500 | $22.79 | 631,099.0000 | 31,289,969 | 1.69% | 0.03% |
| Nov. 7, 2025 | Chevallard Daniel R. | Chief Financial Officer | P | Common Stock | 2178 | $22.76 | 5,386.0000 | 31,289,969 | 67.89% | 0.01% |
| Nov. 7, 2025 | Chevallard Daniel R. | Chief Financial Officer | P | Common Stock | 20 | $22.71 | 3,208.0000 | 31,289,969 | 0.63% | 0.00% |
| Sept. 30, 2025 | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 57502 | $46.41 | 2,657,011.0000 | 27,542,874 | 2.12% | 0.21% |
| Sept. 30, 2025 | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 177 | $47.01 | 2,656,888.0000 | 27,542,874 | 0.01% | 0.00% |
| Sept. 30, 2025 | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 123 | $47.01 | 2,656,888.0000 | 27,542,874 | 0.00% | 0.00% |
| Sept. 30, 2025 | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 34405 | $45.35 | 2,714,513.0000 | 27,542,874 | 1.25% | 0.12% |
| Sept. 30, 2025 | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 83066 | $46.41 | 2,657,065.0000 | 27,542,874 | 3.03% | 0.30% |
| Sept. 30, 2025 | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 49701 | $45.35 | 2,740,131.0000 | 27,542,874 | 1.78% | 0.18% |
| Sept. 18, 2025 | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 24370 | $41.59 | 2,902,142.0000 | 27,542,874 | 0.83% | 0.09% |
| Sept. 18, 2025 | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 132 | $43.30 | 2,881,862.0000 | 27,542,874 | 0.00% | 0.00% |
| Sept. 18, 2025 | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 268 | $43.30 | 2,881,862.0000 | 27,542,874 | 0.01% | 0.00% |
| Sept. 18, 2025 | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 20148 | $43.00 | 2,881,994.0000 | 27,542,874 | 0.69% | 0.07% |
| Sept. 18, 2025 | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 40907 | $43.00 | 2,882,130.0000 | 27,542,874 | 1.40% | 0.15% |
| Sept. 18, 2025 | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 49479 | $41.59 | 2,923,037.0000 | 27,542,874 | 1.66% | 0.18% |
| Aug. 22, 2025 | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 10076 | $40.03 | 3,069,161.0000 | 27,542,874 | 0.33% | 0.04% |
| Aug. 22, 2025 | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 5668 | $40.59 | 3,117,028.0000 | 27,542,874 | 0.18% | 0.02% |
| Aug. 25, 2025 | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 24760 | $39.53 | 3,041,592.0000 | 27,542,874 | 0.81% | 0.09% |
| Aug. 25, 2025 | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 50270 | $39.53 | 3,066,758.0000 | 27,542,874 | 1.61% | 0.18% |
| Aug. 22, 2025 | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 2809 | $40.59 | 3,066,352.0000 | 27,542,874 | 0.09% | 0.01% |
| Aug. 26, 2025 | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 1707 | $39.50 | 3,017,166.0000 | 27,542,874 | 0.06% | 0.01% |
| Aug. 26, 2025 | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 3465 | $39.50 | 3,017,166.0000 | 27,542,874 | 0.11% | 0.01% |
| Aug. 26, 2025 | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 21661 | $38.97 | 3,018,873.0000 | 27,542,874 | 0.71% | 0.08% |
| Aug. 26, 2025 | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 43978 | $38.97 | 3,020,631.0000 | 27,542,874 | 1.44% | 0.16% |
| Aug. 25, 2025 | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 2149 | $39.92 | 3,064,609.0000 | 27,542,874 | 0.07% | 0.01% |
| Aug. 25, 2025 | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 1058 | $39.92 | 3,040,534.0000 | 27,542,874 | 0.03% | 0.00% |
| Aug. 22, 2025 | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 20493 | $40.03 | 3,122,696.0000 | 27,542,874 | 0.65% | 0.07% |
| Aug. 18, 2025 | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 15085 | $38.56 | 3,205,260.0000 | 27,542,874 | 0.47% | 0.05% |
| Aug. 15, 2025 | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 69949 | $39.50 | 3,220,345.0000 | 27,542,874 | 2.13% | 0.25% |
| Aug. 15, 2025 | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 145051 | $39.50 | 3,235,888.0000 | 27,542,874 | 4.29% | 0.53% |
| Aug. 18, 2025 | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 30628 | $38.56 | 3,205,260.0000 | 27,542,874 | 0.95% | 0.11% |
| July 10, 2025 | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 191376 | $34.00 | 3,465,973.0000 | 27,542,874 | 5.23% | 0.69% |
| June 27, 2025 | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 200000 | $30.47 | 3,657,349.0000 | 27,542,874 | 5.18% | 0.73% |
| June 18, 2025 | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 100000 | $29.95 | 3,958,226.0000 | 27,542,874 | 2.46% | 0.36% |
| June 20, 2025 | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 100877 | $30.35 | 3,857,349.0000 | 27,542,874 | 2.55% | 0.37% |
| June 20, 2025 | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 133924 | $30.25 | 3,857,349.0000 | 27,542,874 | 3.36% | 0.49% |
| June 10, 2025 | Versant Venture Capital VI, L.P. | Not found | S | Common Stock | 350000 | $29.00 | 4,192,150.0000 | 27,542,874 | 7.71% | 1.27% |
| June 11, 2025 | Thunen Shelley B | Director | A | Stock Option (right to buy) | 13500 | $0.00 | 13,500.0000 | 27,542,874 | 9999.99% | 0.05% |
| June 11, 2025 | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Stock Option (right to buy) | 13500 | $0.00 | 13,500.0000 | 27,542,874 | 9999.99% | 0.05% |
| June 11, 2025 | George Jeffrey P. | Director | A | Stock Option (right to buy) | 13500 | $0.00 | 13,500.0000 | 27,542,874 | 9999.99% | 0.05% |
| June 11, 2025 | Drapkin Kimberlee C | Director | A | Stock Option (right to buy) | 13500 | $0.00 | 13,500.0000 | 27,542,874 | 9999.99% | 0.05% |
| June 11, 2025 | Guerard Frederic | Director | A | Stock Option (right to buy) | 13500 | $0.00 | 13,500.0000 | 27,542,874 | 9999.99% | 0.05% |
| June 11, 2025 | MCCOLLUM JAMES W | Director | A | Stock Option (right to buy) | 13500 | $0.00 | 13,500.0000 | 27,542,874 | 9999.99% | 0.05% |
| June 11, 2025 | Scheiner Zachary | Director | A | Stock Option (right to buy) | 13500 | $0.00 | 13,500.0000 | 27,542,874 | 9999.99% | 0.05% |
| April 9, 2025 | Olsson Shawn | Chief Commercial Officer | M | Common Stock | 1400 | $2.08 | 4,733.0000 | 27,542,874 | 42.00% | 0.01% |
| April 9, 2025 | Olsson Shawn | Chief Commercial Officer | M | Stock Option (right to buy) | 1400 | $0.00 | 63,241.0000 | 27,542,874 | 2.17% | 0.01% |
| March 7, 2025 | Schimmelpennink Evert B. | President, CEO and Secretary | M | Stock Option (right to buy) | 4200 | $0.00 | 337,906.0000 | 0 | 1.23% | 0.00% |
| March 7, 2025 | Schimmelpennink Evert B. | President, CEO and Secretary | M | Common Stock | 4200 | $1.04 | 49,200.0000 | 0 | 9.33% | 0.00% |
| Jan. 9, 2025 | Chevallard Daniel R. | Chief Financial Officer | A | Stock Option (right to buy) | 70444 | $0.00 | 70,444.0000 | 0 | 9999.99% | 0.00% |
| Jan. 9, 2025 | Schimmelpennink Evert B. | President, CEO and Secretary | A | Stock Option (right to buy) | 279100 | $0.00 | 279,100.0000 | 0 | 9999.99% | 0.00% |
| Jan. 9, 2025 | Olsson Shawn | Chief Commercial Officer | A | Stock Option (right to buy) | 80100 | $0.00 | 80,100.0000 | 0 | 9999.99% | 0.00% |
| Jan. 9, 2025 | Odrich Marc | Chief Medical Officer | A | Stock Option (right to buy) | 80100 | $0.00 | 80,100.0000 | 0 | 9999.99% | 0.00% |
| Dec. 16, 2024 | Olsson Shawn | Chief Commercial Officer | M | Stock Option (right to buy) | 3333 | $0.00 | 64,641.0000 | 0 | 4.90% | 0.00% |
| Dec. 16, 2024 | Olsson Shawn | Chief Commercial Officer | M | Common Stock | 3333 | $2.08 | 3,333.0000 | 0 | 9999.99% | 0.00% |
| July 22, 2024 | Schimmelpennink Evert B. | President, CEO and Secretary | M | Stock Option (right to buy) | 45000 | $0.00 | 342,106.0000 | 0 | 11.62% | 0.00% |
| July 22, 2024 | Schimmelpennink Evert B. | President, CEO and Secretary | M | Common Stock | 45000 | $1.04 | 45,000.0000 | 0 | 9999.99% | 0.00% |
| May 14, 2024 | Chevallard Daniel R. | Chief Financial Officer | P | Common Stock | 3188 | $15.68 | 3,188.0000 | 0 | 9999.99% | 0.00% |
| May 13, 2024 | MCCOLLUM JAMES W | Director | P | Common Stock | 31332 | $15.99 | 620,599.0000 | 0 | 5.32% | 0.00% |
| March 21, 2024 | Drapkin Kimberlee C | Director | A | Stock Option (right to buy) | 27000 | $0.00 | 27,000.0000 | 0 | 9999.99% | 0.00% |
| March 21, 2024 | Scheiner Zachary | Not found | A | Stock Option (right to buy) | 27000 | $0.00 | 27,000.0000 | 0 | 9999.99% | 0.00% |
| March 21, 2024 | Guerard Frederic | Director | A | Stock Option (right to buy) | 27000 | $0.00 | 27,000.0000 | 0 | 9999.99% | 0.00% |
| March 21, 2024 | Guerard Frederic | Director | A | Stock Option (right to buy) | 23571 | $0.00 | 23,571.0000 | 0 | 9999.99% | 0.00% |
| March 21, 2024 | Guerard Frederic | Director | A | Stock Option (right to buy) | 30897 | $0.00 | 30,897.0000 | 0 | 9999.99% | 0.00% |
| March 21, 2024 | MCCOLLUM JAMES W | Director | A | Stock Option (right to buy) | 27000 | $0.00 | 27,000.0000 | 0 | 9999.99% | 0.00% |
| March 21, 2024 | MCCOLLUM JAMES W | Director | A | Warrant (right to buy) | 6575 | $0.00 | 6,575.0000 | 0 | 9999.99% | 0.00% |
| March 21, 2024 | MCCOLLUM JAMES W | Director | A | Common Stock | 16633 | $15.03 | 589,267.0000 | 0 | 2.90% | 0.00% |
| March 21, 2024 | MCCOLLUM JAMES W | Director | A | Common Stock | 477600 | $0.00 | 572,634.0000 | 0 | 502.56% | 0.00% |
| March 21, 2024 | MCCOLLUM JAMES W | Director | A | Common Stock | 95034 | $0.00 | 589,267.0000 | 0 | 19.23% | 0.00% |
| March 21, 2024 | Thunen Shelley B | Director | A | Stock Option (right to buy) | 27000 | $0.00 | 27,000.0000 | 0 | 9999.99% | 0.00% |
| March 21, 2024 | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Stock Option (right to buy) | 27000 | $0.00 | 27,000.0000 | 0 | 9999.99% | 0.00% |
| March 21, 2024 | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Warrants (Right to Buy) | 5371 | $0.00 | 5,371.0000 | 0 | 9999.99% | 0.00% |
| March 21, 2024 | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Warrants (Right to Buy) | 10580 | $0.00 | 10,580.0000 | 0 | 9999.99% | 0.00% |
| March 21, 2024 | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Warrants (Right to Buy) | 54582 | $0.00 | 54,582.0000 | 0 | 9999.99% | 0.00% |
| March 21, 2024 | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Common Stockj | 64971 | $15.03 | 694,755.0000 | 0 | 10.32% | 0.00% |
| March 21, 2024 | Odrich Marc | Chief Medical Officer | A | Stock Option (right to buy) | 66472 | $0.00 | 66,472.0000 | 0 | 9999.99% | 0.00% |
| March 21, 2024 | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Common Stock | 164729 | $0.00 | 859,484.0000 | 0 | 23.71% | 0.00% |
| March 21, 2024 | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Common Stock | 694755 | $0.00 | 4,014,094.0000 | 0 | 20.93% | 0.00% |
| March 21, 2024 | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Common Stock | 2386301 | $0.00 | 5,705,640.0000 | 0 | 71.89% | 0.00% |
| March 21, 2024 | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Common Stock | 933038 | $15.03 | 4,014,094.0000 | 0 | 30.28% | 0.00% |
| March 21, 2024 | Odrich Marc | Chief Medical Officer | A | Stock Option (right to buy) | 105000 | $0.00 | 105,000.0000 | 0 | 9999.99% | 0.00% |
| March 21, 2024 | Schimmelpennink Evert B. | President, CEO and Secretary | A | Stock Option (right to buy) | 387106 | $0.00 | 387,106.0000 | 0 | 9999.99% | 0.00% |
| March 21, 2024 | Schimmelpennink Evert B. | President, CEO and Secretary | A | Stock Option (right to buy) | 82723 | $0.00 | 82,723.0000 | 0 | 9999.99% | 0.00% |
| March 21, 2024 | Schimmelpennink Evert B. | President, CEO and Secretary | A | Stock Option (right to buy) | 315864 | $0.00 | 315,864.0000 | 0 | 9999.99% | 0.00% |
| March 21, 2024 | Schimmelpennink Evert B. | President, CEO and Secretary | A | Stock Option (right to buy) | 475000 | $0.00 | 475,000.0000 | 0 | 9999.99% | 0.00% |
| March 21, 2024 | Versant Venture Capital VI, L.P. | Not found | J | Common Stock | 598203 | $0.00 | 4,542,150.0000 | 0 | 15.17% | 0.00% |
| March 21, 2024 | Odrich Marc | Chief Medical Officer | A | Common Stock | 99599 | $0.00 | 99,599.0000 | 0 | 9999.99% | 0.00% |
| March 21, 2024 | Olsson Shawn | Chief Commercial Officer | A | Stock Option (right to buy) | 105000 | $0.00 | 105,000.0000 | 0 | 9999.99% | 0.00% |
| March 21, 2024 | Olsson Shawn | Chief Commercial Officer | A | Stock Option (right to buy) | 50915 | $0.00 | 50,915.0000 | 0 | 9999.99% | 0.00% |
| March 21, 2024 | Olsson Shawn | Chief Commercial Officer | A | Stock Option (right to buy) | 30466 | $0.00 | 30,466.0000 | 0 | 9999.99% | 0.00% |
| March 21, 2024 | Olsson Shawn | Chief Commercial Officer | A | Stock Option (right to buy) | 67974 | $0.00 | 67,974.0000 | 0 | 9999.99% | 0.00% |
| March 21, 2024 | Chevallard Daniel R. | Chief Financial Officer | A | Stock Option (right to buy) | 200000 | $0.00 | 200,000.0000 | 0 | 9999.99% | 0.00% |
| March 21, 2024 | George Jeffrey P. | Director | A | Stock Option (right to buy) | 27000 | $0.00 | 27,000.0000 | 0 | 9999.99% | 0.00% |
| July 28, 2023 | Drapkin Kimberlee C | Director | A | Stock Option (right to buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| July 19, 2023 | Hege Kristen | Director | A | Stock Option (right to buy) | 20000 | $0.00 | 20,000.0000 | 0 | 9999.99% | 0.00% |
| July 19, 2023 | Shah Smital | Director | A | Stock Option (right to buy) | 20000 | $0.00 | 20,000.0000 | 0 | 9999.99% | 0.00% |
| July 19, 2023 | Bassan Abraham | Director | A | Stock Option (right to buy) | 20000 | $0.00 | 20,000.0000 | 0 | 9999.99% | 0.00% |
| July 19, 2023 | Carlo Rizzuto | Director | A | Stock Option (right to buy) | 20000 | $0.00 | 20,000.0000 | 0 | 9999.99% | 0.00% |
| July 19, 2023 | Jerel Davis | Director | A | Stock Option (right to buy) | 20000 | $0.00 | 20,000.0000 | 0 | 9999.99% | 0.00% |
| July 19, 2023 | Porteus Matthew | Director | A | Stock Option (right to buy) | 20000 | $0.00 | 20,000.0000 | 0 | 9999.99% | 0.00% |
| July 19, 2023 | Viney Joanne L. | Director | A | Stock Option (right to buy) | 20000 | $0.00 | 20,000.0000 | 0 | 9999.99% | 0.00% |
| July 19, 2023 | JIMENEZ JOSEPH | Director | A | Stock Option (right to buy) | 20000 | $0.00 | 20,000.0000 | 0 | 9999.99% | 0.00% |
| July 19, 2023 | KARSEN PERRY A | Director | A | Stock Option (right to buy) | 20000 | $0.00 | 20,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 21, 2023 | Young Alethia | Chief Financial Officer | A | Stock Option (right to buy) | 220000 | $0.00 | 220,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 21, 2023 | Lehrer-Graiwer Joshua | PRESIDENT AND CEO | A | Stock Option (right to buy) | 600000 | $0.00 | 600,000.0000 | 0 | 9999.99% | 0.00% |